Abattis Bioceuticals

Description

Abattis is a specialty biotechnology company that aggregates, incubates, integrates, and invests in the botanical drug development industry. The Company develops and commercializes natural health (nutraceutical) products and conducts research and development to create plant-based (botanical) intellectual property and ingredients for the pharmaceutical, nutraceutical, bioceutical and cosmetic markets – some of which will contain cannabinoid compounds.

Through our divisions Biocell Labs Inc. and Vergence Sales & Marketing Group, we develop and license natural health products and have future plans to expand into the nutraceutical, pharmaceutical and cosmetic markets. The Company has an extensive pipeline of high-quality products and intellectual property for the rapidly expanding natural health product market. We follow strict standard operating protocols, and adhere to the applicable laws of Canada and foreign jurisdictions.

Within our other divisions Northern Vine, North American Bioextracts and Biocube, as well as investments we have made in companies such as Phytalytics (51%), IPS (51%) and Experion (25%), we have capabilities that support the production and extraction of botanical ingredients for our products; one of which includes cannabis.